IPV ¹é½Å ½ÃÀå : ¹é½Å ºê·£µåº°, À¯Åë ä³Îº°, Áö¿ªº° - ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2025-2032³â)
IPV Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
»óǰÄÚµå
:
1708584
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
IPV ¹é½Å ¼¼°è ½ÃÀåÀº 2025³â 1¾ï 9,990¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 3¾ï 5,850¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2032³â µ¿¾È 8.7%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í¼ ¹üÀ§
º¸°í¼ »ó¼¼
±âÁØ ¿¬µµ
2024³â
2025³â ½ÃÀå ±Ô¸ð
1¾ï 9,990¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR
8.70%
2032³â ±Ý¾× ¿¹Ãø
3¾ï 5,850¸¸ ´Þ·¯
±×¸². IPV ¹é½Å ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
ºÒȰ¼ºÈ ¼Ò¾Æ¸¶ºñ ¹é½Å(IPV)Àº ¼ÒÅ©¹é½ÅÀ̶ó°íµµ ÇÕ´Ï´Ù. ¼Ò¾Æ¸¶ºñ ¹é½Å¿¡´Â ºÒȰ¼ºÈ ¼Ò¾Æ¸¶ºñ ¹é½Å°ú °æ±¸¿ë ¼Ò¾Æ¸¶ºñ ¹é½ÅÀÇ µÎ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, IPV ¹é½ÅÀº ÁÖ·Î ÆÈ°ú ´Ù¸®¿¡ ÁÖ»çÇÕ´Ï´Ù.
°è¶õÀ̳ª ½ºÆ®·¾Å丶À̽Űú °°Àº ¾à¹°¿¡ ¾Ë·¹¸£±â°¡ ÀÖ´Â »ç¶÷Àº IPV Áֻ縦 ¸ÂÀ¸¸é ¾ÈµÇ¸ç, IPV´Â ¹é½Å Á¢Á¾ ´ë»óÀÚ°¡ Àå±â°£ ½ºÅ×·ÎÀ̵å Ä¡·á¸¦ ¹Þ°í Àְųª, ¾ÏÀ» ¾Î°í Àְųª, ÈÇпä¹ýÀ» ¹Þ°í Àְųª, Áý¿¡ ¸é¿ª·ÂÀÌ ¾ø´Â ¼ºÀÎÀÌ ÀÖ´Â °æ¿ì¿¡¸¸ Á¢Á¾ÇØ¾ß ÇÕ´Ï´Ù. °æ¿ì¿¡¸¸ Á¢Á¾ÇÕ´Ï´Ù.
IPV ¹é½Å ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 1¾ï 9,990¸¸ ´Þ·¯·Î 2032³â¿¡´Â 3¾ï 5,850¸¸ ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 8.7%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀå ¿ªÇÐ
¼Ò¾Æ¸¶ºñ ¹ß»ýÀ» ¿¹¹æÇϱâ À§ÇØ ¿©·¯ Á¤ºÎ°¡ ¿¹¹æ Á¢Á¾¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇØ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃëÇϰí ÀÖ½À´Ï´Ù. °ø°ø ±â°üÀº °¡³ÇÑ »ç¶÷µé¿¡°Ô ¿¹¹æÁ¢Á¾À» Á¦°øÇϱâ À§ÇØ À¯ÀÍÇÑ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥À» µµÀÔÇϰí ÀÖÀ¸¸ç, ÀÌ´Â °¡±î¿î Àå·¡¿¡ ¼¼°è ºÒȰ¼ºÈ ¼Ò¾Æ¸¶ºñ ¹é½Å ½ÃÀå(IPV)ÀÇ ¼ºÀå¿¡ ¸Å¿ì À¯¸®ÇÑ È¯°æÀ» Á¶¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 9¿ù °¡³ª º¸°ÇºÎ(GHS)´Â °íÀ§Çè Áö¿ª¿¡¼ÀÇ ¹ÙÀÌ·¯½º È®»êÀ» ¹æÁöÇϱâ À§ÇØ ÀÏ·ÃÀÇ ¼Ò¾Æ¸¶ºñ ¹é½Å Á¢Á¾/¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀ» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ¼Ò¾Æ¸¶ºñ ¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀº ºÒȰ¼ºÈ ¼Ò¾Æ¸¶ºñ ¹é½Å(IPV)À» »ç¿ëÇÏ¿© °¡³ª Àü¿ªÀÇ ¸ðµç Áö¿ª¿¡¼ 2016³â 1¿ùºÎÅÍ 2018³â 6¿ù±îÁö Ãâ»ýÇÑ ¸ðµç ¾î¸°ÀÌ¿¡°Ô ¿¹¹æÁ¢Á¾À» ½Ç½ÃÇϰí ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
ÀÌ º¸°í¼´Â 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È Àü ¼¼°è IPV ¹é½Å ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» »ó¼¼È÷ ºÐ¼®ÇÏ¿´½À´Ï´Ù.
´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ Ã¢Ãâ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
¼¼°è IPV ¹é½Å ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ °³¿ä, ½ÇÀû, Á¦Ç° Æ÷Æ®Æú¸®¿À, ½ÃÀå ÀÔÁö, À¯Åë Àü·«, ÁÖ¿ä °³¹ß, Àü·«, ÇâÈÄ °èȹ µîÀÇ ÆÄ¶ó¹ÌÅ͸¦ ±âÁØÀ¸·Î Á¤¸®ÇÏ¿© ¼ö·ÏÇÏ¿´½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
IPV ¹é½Å ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è IPV ¹é½Å ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤
Á¦2Àå ½ÃÀå °³¿ä
º¸°í¼ ¼³¸í
ÁÖ¿ä ¿ä¾à
½ÃÀå ±âȸ ¸Ê
Á¦3Àå Áß¿äÇÑ ÀλçÀÌÆ®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
PEST ºÐ¼®
Porters ºÐ¼®
±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
¼öÃâÀÔ ºÐ¼®
±ÔÁ¦ ½Ã³ª¸®¿À
°¡°Ý ºÐ¼®
COVID-19ÀÇ ¿µÇ⠺м®
¿ªÇÐ
±¹°¡¿¡ ÀÇÇÑ ÀÇ·áºñ ÁöÃâ
±¹°¡¿¡ ÀÇÇÑ ¹é½Å Á¢Á¾·ü
Á¦Á¶´É·Â
À¯Åë¾÷ü »óȲ
ÅõÀÚ¿Í ÀÚ±Ý Á¶´Þ
°æÀï »óȲ
È÷Æ®¸Ê ºÐ¼®
Á¦4Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, ¹é½Å ºê·£µåº°, 2020-2032³â
¼Ò°³
POLIOVAC(PFS/SD)
SHANIPV
POLIORIX
IPOL/IMOVAX
POLYMILEX
Á¦5Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, ¹é½Å À¯Çüº°, 2020-2032³â
Á¦6Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, ¹ÙÀÌ¾Ë À¯Çüº°, 2020-2032³â
¼Ò°³
1ȸºÐ ¹ÙÀ̾Ë
5ȸºÐ ¹ÙÀ̾Ë
10ȸºÐ ¹ÙÀ̾Ë
Á¦7Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â
Á¦8Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, Áö¿ªº°, 2020-2032³â
¼Ò°³
ºÏ¹Ì
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä«
秵¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
Á¦10Àå ±â¾÷ °³¿ä - ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå
Sanofi
Serum Institute of India Pvt. Ltd.
Bharat BIoTech
Merck & Co., Inc.
GlaxoSmithKline
AJ Vaccines A/S
Panacea BIoTec
Biken
Sinopharm Group Co. Ltd.
Nanolek
IMBCAMS
Sinovac BIoTech
LG Chem
Beijing Minhai Biological Technology Co., Ltd.
Biological E Limited
Section 10
À¶¼º°ú ¼èÅð
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
Coherent Opportunity Map
Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý
ksm
¿µ¹® ¸ñÂ÷
Global Ipv Vaccines Market is estimated to be valued at USD 199.9 Mn in 2025 and is expected to reach USD 358.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 199.9 Mn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
8.70%
2032 Value Projection:
USD 358.5 Mn
Figure. Ipv Vaccines Market Share (%), By Region 2025
Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.
Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.
Global IPV vaccines market was valued at USD 199.9 Mn in 2025 and is expected to increase to US$ 358.5 Mn by 2032, registering a CAGR of 8.7% over the forecast period.
Market Dynamics
Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.
Key features of the study:
This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market
Detailed Segmentation:
Global IPV Vaccines Market, by Vaccine Brand:
Poliovac (Pfs/Sd)
Shanipv
Poliorix
Ipol/Imovax
Polymilex
Global IPV Vaccines Market, by Distribution Channel:
Global IPV Vaccines Market, by Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles
GlaxoSmithKline Plc
Sanofi S.A.
Serum Institute of India Pvt. Ltd.
PT Bio Farma
AJ Vaccines
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Vaccine Brand
Market Snapshot, By Vaccine Type
Market Snapshot, By Vial Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map
3. Key Insights
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Company Market Share Analysis
Import-Export Analysis
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Epidemiology
Healthcare Spending, by Country
Vaccination Rate, by Country
Manufacturing Capacities
Distributors Landscape
Investments & Funding
Competitive Snapshot
Heat Map Analysis
4. Global IPV Vaccines Market, By Vaccine Brand, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
POLIOVAC (PFS/SD), 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
SHANIPV, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
POLIORIX, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
IPOL/IMOVAX, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
POLYMILEX, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
5. Global IPV Vaccines Market, By Vaccine Type, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
Combination Vaccine, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
Single Vaccine, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
6. Global IPV Vaccines Market, By Vial Type, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
1 Dose Vial, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
5 Dose Vial, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
10 Dose Vial, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
7. Global IPV Vaccines Market, By Distribution Channel, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
Public, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
Private, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
8. Global IPV Vaccines Market, By Region, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Million)
Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Million)
Regional Trends
North America
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
Europe
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
GCC
Israel
Rest Of The Middle East
Africa
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Million)
South Africa
North Africa
Central Africa
9. Competitive Landscape
Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2025 - Global
10. Company Profiles - Global IPV Vaccines Market
Sanofi*
Company Overview
Product/Service Portfolio
Financial Performance
Recent Developments/Updates
Strategic Overview
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Merck & Co., Inc.
GlaxoSmithKline
AJ Vaccines A/S
Panacea Biotec
Biken
Sinopharm Group Co. Ltd.
Nanolek
IMBCAMS
Sinovac Biotech
LG Chem
Beijing Minhai Biological Technology Co., Ltd.
Biological E Limited.
Section 10: Wheel of Fortune
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us and Sales Contact
°ü·ÃÀÚ·á